-
Mashup Score: 14AAPA Conference 2024 - 4 day(s) ago
Join us at AAPA 2024 in Houston to discover new ways to care for patients and push your profession forward.
Source: www.aapa.orgCategories: General Medicine News, CardiologistsTweet
-
Mashup Score: 4The High Cost of Abandoning GLP1 Therapy for Obesity - 6 day(s) ago
Moving Beyond Marketing Hype
Source: medium.comCategories: General Medicine News, CardiologistsTweet
-
Mashup Score: 1Lake Mead park rangers trying to identify 2 visitors seen on video destroying ancient rock formations | CNN - 12 day(s) ago
Two visitors at Lake Mead National Recreation Area were captured on video destroying ancient rock formations and park rangers are seeking the public’s help in identifying the suspects.
Source: www.cnn.comCategories: General Medicine News, CardiologistsTweet
-
Mashup Score: 1
This ecological study using data from the SEER cancer registries examines the associations between rates of mammography screening and the incidence of breast cancer, mortality from breast cancer, and tumor size.
Source: jamanetwork.comCategories: General Medicine News, CardiologistsTweet
-
Mashup Score: 0
Theodore Bartholomew, Mirela Colleoni, and Harald Schmidt argue that the focus should be on decision making not uptake when the balance of benefit and harm is subjective Breast cancer is the most common cause of cancer death for women worldwide.1 Various measures have been explored to reduce breast cancer mortality. One approach is to encourage screening through financial incentives for patients or providers, as recently proposed in France and the UK, respectively.234 Several countries already use some form of incentive, and the extent to which they are being offered, in combination with ambitious screening targets, could suggest that their use is an appropriate way to promote population health. This, however, is far from clear: there are major concerns about breast cancer screening, the effectiveness of financial incentives is unclear, and there is an urgent need to ensure that women have given their valid consent—that is, informed and without undue influence—for screening. Some trans
Source: www.bmj.comCategories: General Medicine News, CardiologistsTweet-
It is beyond comprehension to advocate and pay for “screening” and then leave patients high and dry when screening results lead them “down the path”. In particular, a screening that results in far more psychological and physical harm than lives saved. 😞 https://t.co/17AoRSeBkb https://t.co/8wWK0Z3gum
-
-
Mashup Score: 1TikTok · Kaycee Rice Fanpage - 15 day(s) ago
1.4M likes, 15.6K comments. “CDK contemporary”
Source: www.tiktok.comCategories: General Medicine News, CardiologistsTweet
-
Mashup Score: 2Home Page - Office of Minority Health (OMH) - 19 day(s) ago
The Office of Minority Health (OMH) mission is to improve the health of racial and ethnic populations.
Source: minorityhealth.hhs.govCategories: General Medicine News, CardiologistsTweet
-
Mashup Score: 8Ozempic and Wegovy: 5 Health Benefits Besides Weight Loss - 22 day(s) ago
In addition to treating diabetes and obesity, GLP-1 drugs like Ozempic, Wegovy, Mounjaro, and Zepbound may also help reduce the risk of several other health conditions.
Source: www.healthline.comCategories: General Medicine News, CardiologistsTweet
-
Mashup Score: 4Effect of Disodium EDTA Chelation Regimen on Cardiovascular Events in Patients With Previous Myocardial Infarction: The TACT Randomized Trial - 25 day(s) ago
Lamas et al report results of the Trial to Assess Chelation Therapy (TACT), a randomized controlled trial analyzing whether EDTA-based chelation therapy reduced cardiovascular events in 1708 patients with a history of myocardial infarction. In editorials, Nissen and Bauchner et al discuss the…
Source: jamanetwork.comCategories: General Medicine News, CardiologistsTweet
-
Mashup Score: 38
for diagnosis and staging. Growing evidence suggests that the gut microbiome plays a significant role in the occurrence and progression of NAFLD by causing immune dysregulation and metabolic alterations due to gut dysbiosis. The rapid advancement of sequencing tools and metabolomics has enabled the identification of alterations in microbiome signatures and gut microbiota-derived metabolite profiles in numerous clinical studies related to NAFLD. Overall, these studies have shown a decrease in α-diversity and changes in gut microbiota abundance, characterized by increased levels of Escherichia and Prevotella, and decreased levels of Akkermansia muciniphila and Faecalibacterium in patients with NAFLD. Furthermore, bile acids, short-chain fatty acids, trimethylamine N-oxide, and tryptophan metabolites are believed to be closely associated with the onset and progression of NAFLD. In this review, we provide novel insights into the vital role of gut microbiome in the pathogenesis of NAFLD. Sp
Source: journals.lww.comCategories: General Medicine News, CardiologistsTweet
We're headed to #AAPA24, the world's largest PA and PA student conference and expo! 🤩 Join us to connect, collaborate, and shape the future of #healthcare with PAs from across the country. Make sure to register! https://t.co/LzWjWfAqMy @aapaorg @Lross246 and @camille_dyer https://t.co/szvO43bwxh